MarketsandMarkets Blog

According to a new market research report “Real World Evidence Solutions Market by Component (Dataset, (Claims, Clinical, Pharmacy, Patient), Services), Therapeutic Area (Oncology, Cardiovascular, Immunology), End User (Pharmaceuticals, Medical Devices, Payers, Providers) – Global Forecast to 2023 “, published by MarketsandMarkets™, the market is expected to reach USD 1,348.1 million by...

The growth of this market is majorly driven by the rising geriatric population (and the subsequent increase in the prevalence of chronic diseases), shift from volume- to value-based care, and delays in drug development (and the subsequent increase in development costs). What the Market Looks Like? Predicted to grow at a CAGR of 14.3 % during the forecast period, the global Real World Evidence...

The growth of this market is majorly driven by the rising geriatric population (and the subsequent increase in the prevalence of chronic diseases), shift from volume- to value-based care, and delays in drug development (and the subsequent increase in development costs). The Real World Evidence Solutions market is projected to reach USD 1,348.1 million by 2023 from USD 689.9 million in 2018, at...

Real-world evidence is the clinical evidence regarding the usage and potential benefits or risks of a medical product derived from the analysis of real-world data. Real-world data (RWD) is defined as data derived from a number of sources that are associated with outcomes in a heterogeneous patient population in real-world settings. Market Size The global Real World Evidence Solutions Market...